Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage

Liver damage can lead to secondary organ damage by toxic substances and catabolic products accumulation which can increase the permeability of blood-brain barrier, leading to cognitive impairment. The only real treatment for end stage liver failure is grafting. With some, but not all, neurological s...

Full description

Bibliographic Details
Main Authors: Shandiz Morega, Bogdan Cătălin, Cristiana Eugenia Simionescu, Konstantinos Sapalidis, Ion Rogoveanu
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/11/12/1622
_version_ 1797506463684362240
author Shandiz Morega
Bogdan Cătălin
Cristiana Eugenia Simionescu
Konstantinos Sapalidis
Ion Rogoveanu
author_facet Shandiz Morega
Bogdan Cătălin
Cristiana Eugenia Simionescu
Konstantinos Sapalidis
Ion Rogoveanu
author_sort Shandiz Morega
collection DOAJ
description Liver damage can lead to secondary organ damage by toxic substances and catabolic products accumulation which can increase the permeability of blood-brain barrier, leading to cognitive impairment. The only real treatment for end stage liver failure is grafting. With some, but not all, neurological symptoms subsiding after transplantation, the presence of brain damage can impair both the short and long-term outcome. We tested if Cerebrolysin can prevent brain injury in an experimental model of non-viral liver damage in mice. Behavior, abdominal ultrasound evaluation and immunohistochemistry were used to evaluate the animals. No ultrasound or behavior differences were found between the control and treated animals, with both groups displaying more anxiety and no short-term memory benefit compared to sham mice. Cerebrolysin treatment was able to maintain a normal level of cortical NeuN<sup>+</sup> cells and induced an increase in the area occupied by BrdU<sup>+</sup> cells. Surprisingly, no difference was observed when investigating Iba1<sup>+</sup> cells. With neurological complications of end-stage liver disease impacting the rehabilitation of patients receiving liver grafts, a neuroprotective treatment of patients on the waiting lists might improve their rehabilitation outcome by ensuring a minimal cerebral damage.
first_indexed 2024-03-10T04:33:01Z
format Article
id doaj.art-ac8a9bbbf6474f1abdde5b92273abd80
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T04:33:01Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-ac8a9bbbf6474f1abdde5b92273abd802023-11-23T04:02:14ZengMDPI AGBrain Sciences2076-34252021-12-011112162210.3390/brainsci11121622Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver DamageShandiz Morega0Bogdan Cătălin1Cristiana Eugenia Simionescu2Konstantinos Sapalidis3Ion Rogoveanu4U.M.F. Doctoral School Craiova, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaExperimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaDepartment of Pathology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania3rd Department of Surgery, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceGastroenterology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, RomaniaLiver damage can lead to secondary organ damage by toxic substances and catabolic products accumulation which can increase the permeability of blood-brain barrier, leading to cognitive impairment. The only real treatment for end stage liver failure is grafting. With some, but not all, neurological symptoms subsiding after transplantation, the presence of brain damage can impair both the short and long-term outcome. We tested if Cerebrolysin can prevent brain injury in an experimental model of non-viral liver damage in mice. Behavior, abdominal ultrasound evaluation and immunohistochemistry were used to evaluate the animals. No ultrasound or behavior differences were found between the control and treated animals, with both groups displaying more anxiety and no short-term memory benefit compared to sham mice. Cerebrolysin treatment was able to maintain a normal level of cortical NeuN<sup>+</sup> cells and induced an increase in the area occupied by BrdU<sup>+</sup> cells. Surprisingly, no difference was observed when investigating Iba1<sup>+</sup> cells. With neurological complications of end-stage liver disease impacting the rehabilitation of patients receiving liver grafts, a neuroprotective treatment of patients on the waiting lists might improve their rehabilitation outcome by ensuring a minimal cerebral damage.https://www.mdpi.com/2076-3425/11/12/1622liver transplantationneurological complicationsneuroprotection
spellingShingle Shandiz Morega
Bogdan Cătălin
Cristiana Eugenia Simionescu
Konstantinos Sapalidis
Ion Rogoveanu
Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
Brain Sciences
liver transplantation
neurological complications
neuroprotection
title Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
title_full Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
title_fullStr Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
title_full_unstemmed Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
title_short Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
title_sort cerebrolysin prevents brain injury in a mouse model of liver damage
topic liver transplantation
neurological complications
neuroprotection
url https://www.mdpi.com/2076-3425/11/12/1622
work_keys_str_mv AT shandizmorega cerebrolysinpreventsbraininjuryinamousemodelofliverdamage
AT bogdancatalin cerebrolysinpreventsbraininjuryinamousemodelofliverdamage
AT cristianaeugeniasimionescu cerebrolysinpreventsbraininjuryinamousemodelofliverdamage
AT konstantinossapalidis cerebrolysinpreventsbraininjuryinamousemodelofliverdamage
AT ionrogoveanu cerebrolysinpreventsbraininjuryinamousemodelofliverdamage